Literature DB >> 19085298

The use of radiotherapy for the treatment of localized orbital amyloidosis.

Mandip Khaira1, Antony Mutamba, George Meligonis, Geoffrey E Rose, Piers N Plowman, Helen O'Donnell.   

Abstract

OBJECTIVE: To describe two patients with localized orbital amyloidosis and the response of their condition to surgical debulking followed by external beam radiotherapy.
DESIGN: Retrospective noncomparative interventional case series. OUTCOME MEASURES: Stabilization or regression of orbital signs after treatment.
METHODS: Patients with biopsy-proven diagnosis of localized progressive orbital amyloidosis received 34 and 30 Gy fractionated external beam radiotherapy. The clinical case notes and histopathology for the two patients were reviewed.
RESULTS: A 69-year-old man with orbital amyloid deposition in association with localized MALT lymphoma had a marked improvement in orbital signs following surgical debulking and radiotherapy, with no recurrence over two years. A 59-year-old woman with localized orbital amyloidosis showed regression of disease after surgical debulking and radiotherapy, with no evidence of recurrence after six years of follow-up.
CONCLUSION: External beam radiotherapy following surgical debulking appears to halt the progression of localized orbital amyloidosis. Radiotherapy may be used in conjunction with surgical debulking of disease.

Entities:  

Mesh:

Year:  2008        PMID: 19085298     DOI: 10.1080/01676830802350216

Source DB:  PubMed          Journal:  Orbit        ISSN: 0167-6830


  11 in total

1.  Adnexal mass secondary to extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with associated amyloid deposition.

Authors:  Neha Mehta; Heiko Schöder; April Chiu; John Kenneth Schoolmeester; Carol Portlock
Journal:  BMJ Case Rep       Date:  2014-11-14

Review 2.  Ocular adnexal and orbital amyloidosis: a case series and literature review.

Authors:  Eduardo R Mora-Horna; Rubí Rojas-Padilla; Vianhi G López; Martín J Guzmán; Ariel Ceriotto; Guillermo Salcedo
Journal:  Int Ophthalmol       Date:  2015-10-14       Impact factor: 2.031

Review 3.  Rare Diseases of the Orbit.

Authors:  Ulrich Kisser; Jens Heichel; Alexander Glien
Journal:  Laryngorhinootologie       Date:  2021-04-30       Impact factor: 1.057

4.  Clinical presentation, treatment, and prognosis of periocular and orbital amyloidosis in a university-based referral center.

Authors:  Orapan Aryasit; Passorn Preechawai; Kanita Kayasut
Journal:  Clin Ophthalmol       Date:  2013-04-30

5.  Macroglossia due to Systemic Amyloidosis: Is There a Role for Radiotherapy?

Authors:  Isabelle Thibault; Isabelle Vallières
Journal:  Case Rep Oncol       Date:  2011-08-18

6.  Systemic amyloidosis with bilateral conjunctival involvement: a case report.

Authors:  Leandro J Correa; J Pablo Maccio; Evangelina Esposito; Rodolfo Monti; M Eugenia Gonzalez-Castellanos; Martin Paradelo; Horacio M Serra; Julio A Urrets-Zavalia
Journal:  BMC Ophthalmol       Date:  2015-07-19       Impact factor: 2.209

7.  Ectropion and Conjunctival Mass in a Patient with Primary Bilateral Conjunctival Amyloidosis.

Authors:  Alessandro Meduri; Miguel Rechichi; Cosimo Mazzotta; Sergio Zaccharia Scalinci; Mahmoud O Jaroudi
Journal:  Case Rep Ophthalmol Med       Date:  2016-11-16

8.  Primary isolated amyloidosis in the extraocular muscle as a rare cause of ophthalmoplegia: A case report and literature review.

Authors:  Noriko Nishikawa; Yuriya Kawaguchi; Ami Konno; Yuya Kitani; Hidehiro Takei; Yasuo Yanagi
Journal:  Am J Ophthalmol Case Rep       Date:  2021-02-26

9.  Focal Amyloidosis of the Orbit Presenting as a Mass: MRI and CT Features.

Authors:  Hasan Yerli; Erdinc Aydin; Suat Avci; Nihan Haberal; Sibel Oto
Journal:  Iran J Radiol       Date:  2011-12-25       Impact factor: 0.212

10.  Primary Isolated Lacrimal Gland Amyloidosis: A Case Report and Review of the Literature.

Authors:  William Evans; Barrett Thompson; Stephen C Dryden; Caroline Awh; Brian Fowler
Journal:  Cureus       Date:  2019-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.